{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2009-N-0665\" and posted_year = 2009 sorted by posted_date descending", "rows": [["FDA-2009-N-0665-0077", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor; Isoflurane", "Rule", "Final Rule", "2009-12-28T05:00:00Z", 2009, 12, null, null, "2013-07-09T18:25:09Z", "E9-30590", 0, 0, "0900006480a72080"], ["FDA-2009-N-0665-0075", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary Supplemental New Aminal Drug Application - [NADA 141-172]", "Supporting & Related Material", "Freedom of Information Summary", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2013-07-09T16:17:26Z", null, 0, 0, "0900006480a6f354"], ["FDA-2009-N-0665-0076", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs: Polysulfated Glycosaminoglycan", "Rule", "Final Rule", "2009-12-21T05:00:00Z", 2009, 12, null, null, "2013-07-09T15:52:49Z", "E9-30222", 0, 0, "0900006480a6eff2"], ["FDA-2009-N-0665-0074", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Ractopamine; Tylosin", "Notice", "Notice of Final Rule", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2013-07-09T16:15:47Z", "E9-29998", 0, 0, "0900006480a6ca39"], ["FDA-2009-N-0665-0073", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - [NADA 141-265] Nufl or Gold Florfenicol (in 2-pyrrolidone and triacetin) Injectable Solution Beef and Non-Lactating Dairy Cattle", "Supporting & Related Material", "Freedom of Information Summary", "2009-12-16T05:00:00Z", 2009, 12, null, null, "2013-07-09T16:25:41Z", null, 0, 0, "0900006480a6ba50"], ["FDA-2009-N-0665-0071", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor; Ketamine - Final Rule", "Notice", "Notice of Final Rule", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2014-07-11T16:32:48Z", "E9-29888", 0, 0, "0900006480a6bb3c"], ["FDA-2009-N-0665-0072", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol", "Notice", "Notice of Final Rule", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2013-07-09T16:24:11Z", "E9-29875", 0, 0, "0900006480a6bb82"], ["FDA-2009-N-0665-0068", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Insulin - Final Rule", "Rule", "Final Rule", "2009-12-14T05:00:00Z", 2009, 12, null, null, "2014-01-08T13:27:08Z", "E9-29583", 0, 0, "0900006480a6a16d"], ["FDA-2009-N-0665-0070", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor", "Rule", "Final Rule", "2009-12-14T05:00:00Z", 2009, 12, null, null, "2013-07-09T18:26:32Z", "E9-29627", 0, 0, "0900006480a6a16e"], ["FDA-2009-N-0665-0069", "FDA", "FDA-2009-N-0665", "PROZINC - Protamine Zinc Recombinant Human Insulin; Injectable Aqueous Suspension , Cats - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-12-14T05:00:00Z", 2009, 12, null, null, "2014-01-08T13:28:35Z", null, 0, 0, "0900006480a6a055"], ["FDA-2009-N-0665-0067", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor; Azaperone", "Notice", "Notice of Final Rule", "2009-12-11T05:00:00Z", 2009, 12, "2009-12-11T05:00:00Z", null, "2013-07-09T18:17:50Z", "E9-29494", 0, 0, "0900006480a692a1"], ["FDA-2009-N-0665-0065", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs: Chlortetracycline Powder - Final Rule", "Rule", "Final Rule", "2009-11-30T05:00:00Z", 2009, 11, null, null, "2014-01-08T12:45:23Z", "E9-28468", 0, 0, "0900006480a60309"], ["FDA-2009-N-0665-0066", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - Original Abbreviated New Animal Drug Application - ANADA 200-441 - A-MYCIN Soluble Powder (chlortetracycline hydrochloride) Chickens, and Growing Turkeys, Swine, and Cattle (Calves, Beef, and Nonlactating dairy)", "Supporting & Related Material", "Freedom of Information Summary", "2009-11-30T05:00:00Z", 2009, 11, null, null, "2014-01-08T12:47:06Z", null, 0, 0, "0900006480a6058e"], ["FDA-2009-N-0665-0064", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor", "Rule", "Final Rule", "2009-11-25T05:00:00Z", 2009, 11, "2009-11-25T05:00:00Z", null, "2013-07-09T18:28:15Z", "E9-28217", 0, 0, "0900006480a5e995"], ["FDA-2009-N-0665-0061", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Melengestrol; Monensin; Tylosin", "Rule", "Final Rule", "2009-11-23T05:00:00Z", 2009, 11, null, null, "2013-07-09T18:06:51Z", "E9-28019", 0, 0, "0900006480a5c836"], ["FDA-2009-N-0665-0062", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - Supplemental New Animal Drug Application - NADA 138-870 - MGA plus RUMENSIN plus Tylan - Melengestrol Acetate and Monensin and Tylosin Phosphate Type A Medicated Articles to be Used in the Manufacture of Type C Medicated Feeds - Heifers Fed in Confinement for Slaughter", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2009-11-23T05:00:00Z", 2009, 11, null, null, "2009-11-23T15:33:02Z", null, 0, 0, "0900006480a5c7aa"], ["FDA-2009-N-0665-0063", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Change of Sponsor", "Rule", "Final Rule", "2009-11-23T05:00:00Z", 2009, 11, null, null, "2013-07-09T18:45:41Z", "E9-28009", 0, 0, "0900006480a5cd02"], ["FDA-2009-N-0665-0060", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - Sulfadimethoxine Soluble Powder (Sulfadimethoxine)", "Supporting & Related Material", "Freedom of Information Summary", "2009-11-20T05:00:00Z", 2009, 11, null, null, "2014-01-08T12:44:33Z", null, 0, 0, "0900006480a5b42b"], ["FDA-2009-N-0665-0059", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs; Sulfadimethoxine - Final Rule", "Notice", "Notice of Final Rule", "2009-11-20T05:00:00Z", 2009, 11, null, null, "2014-01-08T12:43:29Z", "E9-27885", 0, 0, "0900006480a5b477"], ["FDA-2009-N-0665-0058", "FDA", "FDA-2009-N-0665", "Freedon of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-11-19T05:00:00Z", 2009, 11, null, null, "2013-07-09T18:16:35Z", null, 0, 0, "0900006480a5ad14"], ["FDA-2009-N-0665-0057", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Melengestrol; Monensin", "Notice", "Notice of Final Rule", "2009-11-19T05:00:00Z", 2009, 11, "2009-11-19T05:00:00Z", null, "2013-07-09T18:15:25Z", "E9-27744", 0, 0, "0900006480a5ab33"], ["FDA-2009-N-0665-0056", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - NADA 141-302 - EAZI-BREED CIDR Sheep Insert - (Progesterone, Solid Matrix, Sheep (ewes)) - For induction of destrus in ewes (sheep) during seasonal anestrus", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2009-11-17T05:00:00Z", 2009, 11, null, null, "2013-07-09T14:56:58Z", null, 0, 0, "0900006480a5961f"], ["FDA-2009-N-0665-0055", "FDA", "FDA-2009-N-0665", "Certain Other Dosage Form New Animal Drugs; Progesterone Intravaginal Inserts", "Rule", "Final Rule", "2009-11-17T05:00:00Z", 2009, 11, null, null, "2013-07-09T14:49:52Z", "E9-27497", 0, 0, "0900006480a592c7"], ["FDA-2009-N-0665-0054", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor; Sometribove Zinc Suspension", "Notice", "NFR-Notice of Final Rule", "2009-10-16T04:00:00Z", 2009, 10, "2009-10-16T04:00:00Z", null, "2009-10-16T15:59:12Z", "E9-24881", 0, 0, "0900006480a434a8"], ["FDA-2009-N-0665-0053", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin", "Notice", "Notice of Final Rule", "2009-10-16T04:00:00Z", 2009, 10, "2009-10-16T04:00:00Z", null, "2013-07-09T16:23:09Z", "E9-24882", 0, 0, "0900006480a433b8"], ["FDA-2009-N-0665-0052", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Monensin; Tylosin", "Notice", "Notice of Final Rule", "2009-10-15T04:00:00Z", 2009, 10, "2009-10-15T04:00:00Z", null, "2013-07-09T18:23:16Z", "E9-24716", 0, 0, "0900006480a42244"], ["FDA-2009-N-0665-0050", "FDA", "FDA-2009-N-0665", "Container label - Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T19:57:58Z", null, 0, 0, "0900006480a25ce9"], ["FDA-2009-N-0665-0051", "FDA", "FDA-2009-N-0665", "Antizol-Vet - Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T19:58:21Z", null, 0, 0, "0900006480a25ceb"], ["FDA-2009-N-0665-0049", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary (Fomepizole for Injection ( fomepizole) )", "Supporting & Related Material", "Freedom of Information Summary", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2013-07-09T16:08:06Z", null, 0, 0, "0900006480a25ce6"], ["FDA-2009-N-0665-0048", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Fomepizole", "Notice", "Notice of Final Rule", "2009-09-17T04:00:00Z", 2009, 9, "2009-09-17T04:00:00Z", null, "2013-07-09T16:02:13Z", "E9-22384", 0, 0, "0900006480a2532d"], ["FDA-2009-N-0665-0047", "FDA", "FDA-2009-N-0665", "Ophthalmic and Topical Dosage Form New Animal Drugs; Diclofenac", "Rule", "Final Rule", "2009-09-16T04:00:00Z", 2009, 9, "2009-09-16T04:00:00Z", null, "2013-07-09T16:18:44Z", "E9-22292", 0, 0, "0900006480a2469d"], ["FDA-2009-N-0665-0046", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - Original New Animal Drug Application NADA 141-289 - AVIAX II plus STAFAC (Semduramicin sodium biomass and Virginiamycin) Type A medicated articles to be used in the manufacture of Type C medicated feeds - Broiler Chickens", "Supporting & Related Material", "Freedom of Information Summary", "2009-08-18T04:00:00Z", 2009, 8, null, null, "2013-07-09T16:29:15Z", null, 0, 0, "0900006480a0c8eb"], ["FDA-2009-N-0665-0045", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds: Semduramicin; Virginiamycin", "Rule", "Final Rule", "2009-08-18T04:00:00Z", 2009, 8, null, null, "2013-07-09T16:26:50Z", "E9-19738", 0, 0, "0900006480a0c245"], ["FDA-2009-N-0665-0044", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds: Oxytetracycline; Neomycin", "Rule", "Final Rule", "2009-08-13T04:00:00Z", 2009, 8, "2009-08-13T04:00:00Z", null, "2013-07-09T18:03:19Z", "E9-19414", 0, 0, "0900006480a08523"], ["FDA-2009-N-0665-0042", "FDA", "FDA-2009-N-0665", "New Animal Drugs: Nitrofurazone Ointment - Final Rule", "Rule", "Final Rule", "2009-08-03T04:00:00Z", 2009, 8, "2009-08-03T04:00:00Z", null, "2014-01-08T12:47:59Z", "E9-18337", 0, 0, "09000064809ffeea"], ["FDA-2009-N-0665-0043", "FDA", "FDA-2009-N-0665", "ANADA 200-425 - Nitrofurazone Soluble Dressing (Nitrofurazane) Horses - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-08-03T04:00:00Z", 2009, 8, null, null, "2014-01-08T12:48:40Z", null, 0, 0, "09000064809ffff8"], ["FDA-2009-N-0665-0041", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor", "Rule", "Final Rule", "2009-07-22T04:00:00Z", 2009, 7, "2009-07-22T04:00:00Z", null, "2013-07-09T18:39:29Z", "E9-17356", 0, 0, "09000064809f783c"], ["FDA-2009-N-0665-0035", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Ceftiofur Sodium - Final Rule", "Rule", "Final Rule", "2009-07-15T04:00:00Z", 2009, 7, "2009-07-15T04:00:00Z", null, "2014-01-08T12:49:23Z", "E9-16734", 0, 0, "09000064809f1cf3"], ["FDA-2009-N-0665-0036", "FDA", "FDA-2009-N-0665", "Ceftiofur Sodium Sterile Powder (ceftiofur sodium) - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-07-15T04:00:00Z", 2009, 7, null, null, "2014-01-08T12:50:06Z", null, 0, 0, "09000064809f1ed3"], ["FDA-2009-N-0665-0039", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Lasalocid; Roxarsone", "Rule", "Final Rule", "2009-07-15T04:00:00Z", 2009, 7, "2009-07-15T04:00:00Z", null, "2013-07-09T14:20:50Z", "E9-16733", 0, 0, "09000064809f1daf"], ["FDA-2009-N-0665-0037", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Flunixin - Final Rule", "Rule", "Final Rule", "2009-07-15T04:00:00Z", 2009, 7, "2009-07-15T04:00:00Z", null, "2014-01-07T21:46:03Z", "E9-16735", 0, 0, "09000064809f1d64"], ["FDA-2009-N-0665-0040", "FDA", "FDA-2009-N-0665", "AVATEC plus 3-NITRO, Lasalocid Sodium plus Roxarsone, Type A Medicated Articles to be Used in the Manufacture of Type C Medicated Feeds, Growing Turkets  - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-07-15T04:00:00Z", 2009, 7, null, null, "2014-01-08T13:22:19Z", null, 0, 0, "09000064809f1f45"], ["FDA-2009-N-0665-0038", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - Flunixin Injection-S (flunixin meglunime), Injectable Solution, Swine", "Supporting & Related Material", "Freedom of Information Summary", "2009-07-15T04:00:00Z", 2009, 7, null, null, "2014-01-07T21:50:25Z", null, 0, 0, "09000064809f1f43"], ["FDA-2009-N-0665-0034", "FDA", "FDA-2009-N-0665", "Freedom Of Information Summary - Vetoryl Trilostane Capsules", "Supporting & Related Material", "Freedom of Information Summary", "2009-06-29T04:00:00Z", 2009, 6, null, null, "2013-07-09T13:52:15Z", null, 0, 0, "09000064809e1f66"], ["FDA-2009-N-0665-0032", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs: Trilostane - Final Rule", "Notice", "Notice of Final Rule", "2009-06-26T04:00:00Z", 2009, 6, "2009-06-26T04:00:00Z", null, "2014-01-08T13:06:54Z", "E9-15152", 0, 0, "09000064809e1c02"], ["FDA-2009-N-0665-0033", "FDA", "FDA-2009-N-0665", "Vetoryl Trilostane Capsules - Freedom Of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-06-26T04:00:00Z", 2009, 6, null, null, "2014-01-08T13:08:06Z", null, 0, 0, "09000064809e1f63"], ["FDA-2009-N-0665-0031", "FDA", "FDA-2009-N-0665", "Palladia, Toceranib Phosphate, Tablets, Dogs - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-06-18T04:00:00Z", 2009, 6, null, null, "2014-01-08T13:26:12Z", null, 0, 0, "09000064809d28b5"], ["FDA-2009-N-0665-0030", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs; Toceranib - Final Rule", "Rule", "Final Rule", "2009-06-18T04:00:00Z", 2009, 6, "2009-06-18T04:00:00Z", null, "2014-01-08T13:24:48Z", "E9-14299", 0, 0, "09000064809d24c0"], ["FDA-2009-N-0665-0029", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Chlortetracycline", "Rule", "Final Rule", "2009-06-12T04:00:00Z", 2009, 6, "2009-06-12T04:00:00Z", null, "2013-07-09T18:20:51Z", "E9-13849", 0, 0, "09000064809cdaa9"], ["FDA-2009-N-0665-0027", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs: Methimazole - Final Rule", "Rule", "Final Rule", "2009-06-11T04:00:00Z", 2009, 6, "2009-06-11T04:00:00Z", null, "2014-01-08T13:12:43Z", "E9-13685", 0, 0, "09000064809cc342"], ["FDA-2009-N-0665-0028", "FDA", "FDA-2009-N-0665", "Felimazole Coated Tablets, Methimazole, Cats - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-06-11T04:00:00Z", 2009, 6, null, null, "2014-01-08T13:13:47Z", null, 0, 0, "09000064809cc3f8"], ["FDA-2009-N-0665-0026", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor; Fomepizole", "Rule", "Final Rule", "2009-06-05T04:00:00Z", 2009, 6, "2009-06-05T04:00:00Z", null, "2013-07-09T15:59:42Z", "E9-13126", 0, 0, "09000064809c67a5"], ["FDA-2009-N-0665-0025", "FDA", "FDA-2009-N-0665", "Ophthalmic and Topical Dosage Form New Animal Drugs; Change of Sponsor; Diclofenac; Ivermectin Otic Suspension - Final Rule", "Rule", "Final Rule", "2009-06-04T04:00:00Z", 2009, 6, "2009-06-04T04:00:00Z", null, "2014-01-08T13:44:43Z", "E9-13015", 0, 0, "09000064809c4ae9"], ["FDA-2009-N-0665-0024", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Luprostiol", "Rule", "Final Rule", "2009-05-27T04:00:00Z", 2009, 5, "2009-05-27T04:00:00Z", null, "2013-07-09T17:58:46Z", "E9-12269", 0, 0, "09000064809b8f02"], ["FDA-2009-N-0665-0023", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - \"GB Topical Spray (Gentanlicin sulfate and Betamethasone Valerate)\" - [New Animal Drugs; Gentamicin and Betamethasone Spray] re FDA-2009-N-0665-0022", "Supporting & Related Material", "Freedom of Information Summary", "2009-05-15T04:00:00Z", 2009, 5, null, null, "2013-07-09T18:12:49Z", null, 0, 0, "0900006480994d39"], ["FDA-2009-N-0665-0022", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Gentamicin and Betamethasone Spray", "Notice", "Notice of Final Rule", "2009-05-15T04:00:00Z", 2009, 5, "2009-05-15T04:00:00Z", null, "2013-07-09T18:08:15Z", "E9-11368", 0, 0, "0900006480994767"], ["FDA-2009-N-0665-0020", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - NOROCARP Caplets (Carprofen) [New Animal Drugs: Carprofen] re FDA-2009-N-0665-0018", "Supporting & Related Material", "Freedom of Information Summary", "2009-05-12T04:00:00Z", 2009, 5, null, null, "2013-07-08T20:19:47Z", null, 0, 0, "090000648098bad3"], ["FDA-2009-N-0665-0021", "FDA", "FDA-2009-N-0665", "VETORYL - Trilostane Capsules - Dogs [New Animal Drugs: Trilostane] re FDA-2009-N-0665-0019 - Freedom of Information Summary -", "Supporting & Related Material", "Freedom of Information Summary", "2009-05-12T04:00:00Z", 2009, 5, null, null, "2014-01-08T13:16:54Z", null, 0, 0, "090000648098bb19"], ["FDA-2009-N-0665-0019", "FDA", "FDA-2009-N-0665", "New Animal Drugs: Trilostane - Final Rule", "Rule", "Final Rule", "2009-05-11T04:00:00Z", 2009, 5, "2009-05-11T04:00:00Z", null, "2014-01-08T13:14:27Z", "E9-10927", 0, 0, "0900006480987dc5"], ["FDA-2009-N-0665-0018", "FDA", "FDA-2009-N-0665", "New Animal Drugs: Carprofen - Final Rule", "Rule", "Final Rule", "2009-05-11T04:00:00Z", 2009, 5, "2009-05-11T04:00:00Z", null, "2014-01-07T21:42:40Z", "E9-10925", 0, 0, "0900006480987da1"], ["FDA-2009-N-0665-0016", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2009-05-05T04:00:00Z", 2009, 5, "2009-05-05T04:00:00Z", null, "2009-05-05T16:02:55Z", "E9-10262", 0, 0, "0900006480975f81"], ["FDA-2009-N-0665-0017", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage From New Animal Drugs; Change of Sponsor; Repository Corticotropin Injection", "Rule", "Final Rule", "2009-05-05T04:00:00Z", 2009, 5, "2009-05-05T04:00:00Z", null, "2013-07-09T18:36:17Z", "E9-10291", 0, 0, "0900006480975fc4"], ["FDA-2009-N-0665-0015", "FDA", "FDA-2009-N-0665", "Ophthalmic and Topical Dosage Form New Animal Drugs; Selamectin", "Rule", "Final Rule", "2009-04-30T04:00:00Z", 2009, 4, "2009-04-30T04:00:00Z", null, "2013-07-09T16:13:59Z", "E9-09901", 0, 0, "090000648096fd38"], ["FDA-2009-N-0665-0014", "FDA", "FDA-2009-N-0665", "Intramammary Dosage Forms:  Change of Sponsor,", "Rule", "Final Rule", "2009-04-27T04:00:00Z", 2009, 4, "2009-04-27T04:00:00Z", null, "2013-07-09T18:31:07Z", "E9-09527", 0, 0, "090000648096d22e"], ["FDA-2009-N-0665-0013", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs: Fenbendazole Suspension - Notices of Final Rule", "Notice", "Notice of Final Rule", "2009-04-17T04:00:00Z", 2009, 4, null, null, "2013-07-09T18:19:03Z", "E9-08822", 0, 0, "090000648095a465"], ["FDA-2009-N-0665-0012", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs: Tylosin", "Notice", "NFR-Notice of Final Rule", "2009-03-19T04:00:00Z", 2009, 3, null, null, "2009-03-19T14:17:02Z", "E9-06009", 0, 0, "090000648091fb0d"], ["FDA-2009-N-0665-0011", "FDA", "FDA-2009-N-0665", "Freedom of Information Summary - \"Amprolium-P 9.6% Oral Solution\" - [Oral Dosage Form New Animal Drugs: Amprolium] re FDA-2009-N-0665-0010", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2009-03-11T04:00:00Z", 2009, 3, null, null, "2013-07-08T20:31:46Z", null, 0, 0, "090000648090577c"], ["FDA-2009-N-0665-0009", "FDA", "FDA-2009-N-0665", "Other Dosage Form New Animal Drugs: Sevoflurane", "Rule", "Final Rule", "2009-03-11T04:00:00Z", 2009, 3, "2009-03-11T04:00:00Z", null, "2013-07-09T16:13:07Z", "E9-04879", 0, 0, "090000648090506a"], ["FDA-2009-N-0665-0010", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs: Amprolium - Final Rule", "Rule", "Final Rule", "2009-03-11T04:00:00Z", 2009, 3, "2009-03-11T04:00:00Z", null, "2014-01-07T21:51:09Z", "E9-05131", 0, 0, "09000064809050a7"], ["FDA-2009-N-0665-0008", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor: Methoxyflurane", "Notice", "Notice of Final Rule", "2009-03-06T05:00:00Z", 2009, 3, null, null, "2013-07-09T18:22:14Z", "E9-04758", 0, 0, "09000064808f7059"], ["FDA-2009-N-0665-0006", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Ivermectin - Final Rule", "Rule", "Final Rule", "2009-03-02T05:00:00Z", 2009, 3, "2009-03-02T05:00:00Z", null, "2014-01-08T13:47:58Z", "E9-04304", 0, 0, "09000064808e61ca"], ["FDA-2009-N-0665-0007", "FDA", "FDA-2009-N-0665", "Supplemental Abbreviated New Animal Drug Application - PHOENECTIN Injection (Ivermectin), Injection - Cattle and Swine - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-03-02T05:00:00Z", 2009, 3, null, null, "2014-01-08T13:54:47Z", null, 0, 0, "09000064808e62c2"], ["FDA-2009-N-0665-0005", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs: Tiamulin", "Notice", "Notice of Final Rule", "2009-02-13T05:00:00Z", 2009, 2, null, null, "2013-07-09T15:57:51Z", "E9-03131", 0, 0, "09000064808568b6"], ["FDA-2009-N-0665-0002", "FDA", "FDA-2009-N-0665", "The Bc6 rDNA Construct in GTC 155-92 Goats - Freedom of Information Summary", "Supporting & Related Material", "Freedom of Information Summary", "2009-02-11T05:00:00Z", 2009, 2, null, null, "2014-01-08T13:37:17Z", null, 0, 0, "0900006480852a47"], ["FDA-2009-N-0665-0004", "FDA", "FDA-2009-N-0665", "Finding of no Significant Impact - \"The Bc6 rDNA Construct in GTC 155-92 Goats\" - [New Animal Drugs: Bc6 Recombinant Deoxyribonucleic Acid Construct] re FDA-2009-N-0665-0001", "Supporting & Related Material", "FONS-Finding of no Significant Impact", "2009-02-11T05:00:00Z", 2009, 2, null, null, "2009-05-18T16:31:26Z", null, 0, 0, "0900006480852add"], ["FDA-2009-N-0665-0001", "FDA", "FDA-2009-N-0665", "New Animal Drugs: Bc6 Recombinant Deoxyribonucleic Acid Construct", "Rule", "NFR-Notice of Final Rule", "2009-02-11T05:00:00Z", 2009, 2, "2009-02-11T05:00:00Z", null, "2009-02-11T20:28:59Z", "E9-02881", 0, 0, "0900006480852428"], ["FDA-2009-N-0665-0003", "FDA", "FDA-2009-N-0665", "The Bc6 rDNA Construct in GTC 155-92 Goats, Expressing Recombinant Human Antithrombin III - Environmental Assessment", "Supporting & Related Material", "Environmental Assessment", "2009-02-11T05:00:00Z", 2009, 2, null, null, "2014-01-08T13:43:09Z", null, 0, 0, "0900006480852aa5"]], "truncated": false, "filtered_table_rows_count": 77, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2009-N-0665", "p1": "2009"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009", "results": [{"value": "FDA", "label": "FDA", "count": 77, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009", "results": [{"value": "Rule", "label": "Rule", "count": 33, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&document_type=Rule", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 28, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009", "results": [{"value": 2009, "label": 2009, "count": 77, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0665&posted_year=2009&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 374.65491000330076, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}